Depletion of fat-resident Treg cells prevents age-associated insulin resistance

SP Bapat, J Myoung Suh, S Fang, S Liu, Y Zhang… - Nature, 2015 - nature.com
SP Bapat, J Myoung Suh, S Fang, S Liu, Y Zhang, A Cheng, C Zhou, Y Liang, M LeBlanc…
Nature, 2015nature.com
Age-associated insulin resistance (IR) and obesity-associated IR are two physiologically
distinct forms of adult-onset diabetes. While macrophage-driven inflammation is a core
driver of obesity-associated IR,,,,,, the underlying mechanisms of the obesity-independent
yet highly prevalent age-associated IR are largely unexplored. Here we show, using
comparative adipo-immune profiling in mice, that fat-resident regulatory T cells, termed fTreg
cells, accumulate in adipose tissue as a function of age, but not obesity. Supporting the …
Abstract
Age-associated insulin resistance (IR) and obesity-associated IR are two physiologically distinct forms of adult-onset diabetes. While macrophage-driven inflammation is a core driver of obesity-associated IR,,,,,, the underlying mechanisms of the obesity-independent yet highly prevalent age-associated IR are largely unexplored. Here we show, using comparative adipo-immune profiling in mice, that fat-resident regulatory T cells, termed fTreg cells, accumulate in adipose tissue as a function of age, but not obesity. Supporting the existence of two distinct mechanisms underlying IR, mice deficient in fTreg cells are protected against age-associated IR, yet remain susceptible to obesity-associated IR and metabolic disease. By contrast, selective depletion of fTreg cells via anti-ST2 antibody treatment increases adipose tissue insulin sensitivity. These findings establish that distinct immune cell populations within adipose tissue underlie ageing- and obesity-associated IR, and implicate fTreg cells as adipo-immune drivers and potential therapeutic targets in the treatment of age-associated IR.
nature.com